| Jamestown Regional Medical Center Home Health | |
| 2422 20th St Sw, Jamestown, North Dakota 58401 | |
| (701) 952-4847 | |
| Name | Jamestown Regional Medical Center Home Health |
|---|---|
| Location | 2422 20th St Sw, Jamestown, North Dakota |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 357002 |
| Ownership Type | Voluntary Non Profit - Religious Affiliation |
| Service Area Zip Codes | 58401, 58402, 58424, 58433, 58456, 58467, 58472, 58481, 58483, 58492 |
| NPI Number | 1528052511 |
| Organization Name | LUTHERAN CHARITY ASSOCIATION |
| Doing Business As | JAMESTOWN REGIONAL MEDICAL CENTER HOME HEALTH AGENCY |
| Address | 2422 20th St Sw, Jamestown, ND 58401 |
| Phone Number | 701-252-1050 |
News Archive
Scientists at the Whitehead Institute for Biomedical Research have found that a single gene, known as PARK9, protects cells from manganese toxicity and rescues neurons from over-expression of the protein alpha-synuclein.
AccuNurse announces its leadership role with 'meaningful use' requirements by taking its product roadmap a significant step further toward helping long-term care providers prepare for an increasingly competitive market that will reward clinical outcomes.
Spinifex Pharmaceuticals, Inc., a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has agreed to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.
RemedyMD (www.RemedyMD.com), the leading provider of specialty applications for comparative effectiveness research, announced its intent to deliver 100 highly specialized patient, disease and clinical registries in the next 90 days.
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
› Verified 1 days ago
| Quality Rating: |
News Archive
Scientists at the Whitehead Institute for Biomedical Research have found that a single gene, known as PARK9, protects cells from manganese toxicity and rescues neurons from over-expression of the protein alpha-synuclein.
AccuNurse announces its leadership role with 'meaningful use' requirements by taking its product roadmap a significant step further toward helping long-term care providers prepare for an increasingly competitive market that will reward clinical outcomes.
Spinifex Pharmaceuticals, Inc., a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has agreed to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.
RemedyMD (www.RemedyMD.com), the leading provider of specialty applications for comparative effectiveness research, announced its intent to deliver 100 highly specialized patient, disease and clinical registries in the next 90 days.
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 95.8 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 100 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 100 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 78.1 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 91.4 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 100 | 96.4 |
News Archive
Scientists at the Whitehead Institute for Biomedical Research have found that a single gene, known as PARK9, protects cells from manganese toxicity and rescues neurons from over-expression of the protein alpha-synuclein.
AccuNurse announces its leadership role with 'meaningful use' requirements by taking its product roadmap a significant step further toward helping long-term care providers prepare for an increasingly competitive market that will reward clinical outcomes.
Spinifex Pharmaceuticals, Inc., a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has agreed to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.
RemedyMD (www.RemedyMD.com), the leading provider of specialty applications for comparative effectiveness research, announced its intent to deliver 100 highly specialized patient, disease and clinical registries in the next 90 days.
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
› Verified 1 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 67.8 | 79.6 |
| How often patients got better at getting in and out of bed | 78.4 | 81.1 |
| How often patients got better at bathing | 78.5 | 82.3 |
| How often patients’ breathing improved | 79.1 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 90.2 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 70.9 | 75 |
| How often home health patients had to be admitted to the hospital | 16.2 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.4 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 98.1 | 94 |
News Archive
Scientists at the Whitehead Institute for Biomedical Research have found that a single gene, known as PARK9, protects cells from manganese toxicity and rescues neurons from over-expression of the protein alpha-synuclein.
AccuNurse announces its leadership role with 'meaningful use' requirements by taking its product roadmap a significant step further toward helping long-term care providers prepare for an increasingly competitive market that will reward clinical outcomes.
Spinifex Pharmaceuticals, Inc., a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has agreed to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.
RemedyMD (www.RemedyMD.com), the leading provider of specialty applications for comparative effectiveness research, announced its intent to deliver 100 highly specialized patient, disease and clinical registries in the next 90 days.
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
› Verified 1 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Scientists at the Whitehead Institute for Biomedical Research have found that a single gene, known as PARK9, protects cells from manganese toxicity and rescues neurons from over-expression of the protein alpha-synuclein.
AccuNurse announces its leadership role with 'meaningful use' requirements by taking its product roadmap a significant step further toward helping long-term care providers prepare for an increasingly competitive market that will reward clinical outcomes.
Spinifex Pharmaceuticals, Inc., a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has agreed to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.
RemedyMD (www.RemedyMD.com), the leading provider of specialty applications for comparative effectiveness research, announced its intent to deliver 100 highly specialized patient, disease and clinical registries in the next 90 days.
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
› Verified 1 days ago
The patient survey data of Jamestown Regional Medical Center Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 96 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 93 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 96 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 91 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 88 | 78 |
News Archive
Scientists at the Whitehead Institute for Biomedical Research have found that a single gene, known as PARK9, protects cells from manganese toxicity and rescues neurons from over-expression of the protein alpha-synuclein.
AccuNurse announces its leadership role with 'meaningful use' requirements by taking its product roadmap a significant step further toward helping long-term care providers prepare for an increasingly competitive market that will reward clinical outcomes.
Spinifex Pharmaceuticals, Inc., a company focused on the development of new drugs for the treatment of chronic pain, today announces that it has agreed to the sale of Spinifex to Novartis International AG, for an upfront cash consideration of US$200 million plus undisclosed clinical development and regulatory milestone payments.
RemedyMD (www.RemedyMD.com), the leading provider of specialty applications for comparative effectiveness research, announced its intent to deliver 100 highly specialized patient, disease and clinical registries in the next 90 days.
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
› Verified 1 days ago
Jamestown Regional Medical Center Home Health Location: 2422 20th St Sw, Jamestown, North Dakota 58401 Ratings: Phone: (701) 952-4847 |